Zoetis Inc. (ETR:ZOE)
Germany
· Delayed Price · Currency is EUR | Market Cap | 68.46B |
| Revenue (ttm) | 8.94B |
| Net Income (ttm) | 2.40B |
| Shares Out | n/a |
| EPS (ttm) | 5.28 |
| PE Ratio | 28.51 |
| Forward PE | n/a |
| Dividend | 1.68 (1.11%) |
| Ex-Dividend Date | Apr 21, 2025 |
| Volume | 174 |
| Average Volume | 246 |
| Open | 151.38 |
| Previous Close | 151.52 |
| Day's Range | 151.38 - 151.38 |
| 52-Week Range | 136.70 - 179.58 |
| Beta | 0.94 |
| RSI | 46.48 |
| Earnings Date | May 6, 2025 |
About Zoetis
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph... [Read more]
Financial Performance
In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.
Financial numbers in USD Financial StatementsNews
Zoetis' Stock Is About as Cheap as It's Ever Been. 1 Thing to Know Before You Buy.
Zoetis to Host Webcast and Conference Call on First Quarter 2025 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, May 6, 2025. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer ...
Zoetis to Host Webcast and Conference Call on First Quarter 2025 Financial Results
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, May 6, 2025. Chief Executive Officer Kristin Peck...
Zoetis: Lots Of Growth Opportunities For This High-Quality Compounder
Zoetis operates in a growing animal healthcare market, benefiting from trends like pet humanization and medicalization. Read why ZTS stock is a Buy.
Zoetis: Focusing On The High Margin Segments
Zoetis Inc. (ZTS) CFO Wetteny Joseph Hosts Barclays 27th Annual Global Healthcare (Transcript)
My Top 15 High-Growth Dividend Stocks For March 2025
The SPDR S&P 500 ETF Trust stumbled in February but managed to maintain a positive return in 2025. The Top 15 dividend growth stocks for March 2025 offer an average dividend yield of 1.13% and appear ...
Zoetis Inc. (ZTS) BofA Securities 2025 Animal Health Summit (Transcript)
Zoetis to Participate in Upcoming Investor Conferences
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced that a representative from the company will participate in the following investor conferences. Bank of ...
Zoetis CEO on bird flu vaccine
Zoetis received a conditional license for its bird flu vaccine from the US Department of Agriculture to help fight the spread of the disease on poultry farms. Here's what CEO Kristin Peck had to say
Zoetis Avian Influenza Vaccine Secures Conditional Approval In US For Use In Chickens
On Friday, the U.S. Department of Agriculture (USDA) Center for Veterinary Biologics (CVB) issued Zoetis Inc (NYSE: ZTS) a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Vi...
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Zoetis (NYSE: ZTS) has outperformed the market over the past 10 years by 2.1% on an annualized basis producing an average annual return of 13.25%. Currently, Zoetis has a market capitalization of $71...
Zoetis (ZTS) Stock Dips Due to Analyst Price Target Cuts
Zoetis (ZTS) Stock Dips Due to Analyst Price Target Cuts
Why Zoetis Stock Took Another Tumble Today
Zoetis Inc (ZTS) Secures Conditional License for Avian Influenza Vaccine
Zoetis Inc (ZTS) Secures Conditional License for Avian Influenza Vaccine
Zoetis gains conditional license for avian flu vaccine in chickens
US grants conditional clearance to Zoetis' bird flu vaccine for poultry
Zoetis said on Friday its bird flu vaccine has received the U.S. Department of Agriculture's conditional license for use in poultry.
Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus
Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype,...
Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #HPAI--Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional lice...
Zoetis CEO says Avian Flu vaccine for poultry gets USDA approval
Zoetis CEO Kristin Peck joins 'Closing Bell Overtime' to talk its Avian Flu vaccine, the impact of tariffs, and more.
Zoetis CEO says Avian Flu vaccine for poultry gets USDA approval
Zoetis CEO Kristin Peck joins 'Closing Bell Overtime' to talk its Avian Flu vaccine, the impact of tariffs, and more.
Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity
Zoetis Inc. (ZTS) Q4 2024 Earnings Call Transcript
Why Zoetis Stock Was Falling Today
Zoetis (ZTS) Q4 2024 Earnings Call Transcript
ZTS earnings call for the period ending December 31, 2024.